Health Care Counsel Blog
809 total results. Page 8 of 33.
Darrell S. Gay, Jill A. Steinberg, Michelle Mancino Marsh
In this clip from our webinar, “Legal and Operational Considerations for Healthcare Employers During This Ever Changing Time of COVID and Vaccines,” Health Care Partner Jill Steinberg addresses the operational and regulatory concerns of mandating the COVID-19 vaccine.
Stephanie Trunk
The United States Supreme Court has agreed to hear a case that has a direct impact on the 340B Drug Discount Program (the 340B Program) and how Medicare will reimburse hospitals for dispensing of 340B covered drugs, as well as other reimbursement issues.
D. Jacques Smith, Randall A. Brater, Mattie Bowden
On June 23, 2021, CVS Pharmacy Inc. was cleared of claims of overcharging drug purchasers by more than $121 million for general drugs. This verdict comes after a week-long trial in the Northern District of California beginning June 7, 2021.
June 24, 2021 12:00 PM - 1:30 PM
Lowell C. Brown, Annie Chang Lee
Health Care Partner Lowell Brown and Associate Annie Chang Lee will present as part of the California Association Medical Staff Services’ (CAMSS) 50th Annual Education Forum on June 24, 2021.
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Mohammed T. Farooqui
On June 15, 2021, the Department of Justice (DOJ) filed a False Claims Act (FCA) suit against Paksn Inc., Prema Thekkek and one of its owners, and seven skilled nursing facilities (SNFs) owned by Thekkek and/or operated by Paksn.
Darrell S. Gay, Jill A. Steinberg, Michelle Mancino Marsh
Our panel offers insight on providing incentives vs. mandating the COVID-19 vaccine during the “Legal and Operational Considerations for Healthcare Employers During This Ever Changing Time of COVID and Vaccines” webinar.
Darrell S. Gay, Jill A. Steinberg, Michelle Mancino Marsh
Our panel kicks off the “Legal and Operational Considerations for Healthcare Employers During This Ever Changing Time of COVID and Vaccines” webinar with this timely question.
Douglas A. Grimm
Take note, all providers who received Provider Review Fund (PRF) payments – there are changes in the reporting deadlines and requirements.
Emily M. Leongini
On March 31, 2021, New York Governor Andrew Cuomo signed the Marijuana Regulation and Taxation Act (MRTA) into law, legalizing adult-use cannabis in the state and establishing a regulatory framework to govern what likely will be one of the nation’s largest cannabis markets.
Stephanie Trunk
In July 2020, the Trump Administration issued an Executive Order (the EO) directing the Secretary of the Department of Health and Human Services (HHS) to take certain actions and finalize rulemakings designed to “support the goal of safe importation of prescription drugs.”
Debra Albin-Riley
Los Angeles Partner Debra Albin-Riley recently argued before the California Supreme Court in a closely-watched case involving the scope of anti-SLAPP protection for medical staff peer review.
June 8, 2021 - June 11, 2021
Stephanie Trunk
Health Care Partner Stephanie Trunk is presenting twice at the Informa Medicaid & Government Pricing Congress June 8-11, 2021.
Stephanie Trunk
The Minnesota Department of Health (MDH) will host a public, virtual meeting on Thursday, June 10, 2021, at 1 p.m. Central time to present and request feedback on draft reporting guidelines for the Minnesota Prescription Drug Price Transparency Act (Minnesota Statutes 62.J.84).
June 3, 2021 11:00 AM - 11:50 AM
Anne M. Murphy
Join Arent Fox Partner Anne Murphy as she moderates a panel on Emerging Governance Issues for health care organizations.
D. Jacques Smith, Randall A. Brater, Alexander S. Birkhold
On May 21, 2021, SavaSeniorCare LLC and several of its affiliates, which own and operate skilled nursing facilities across the country, agreed to pay $11.2 million to resolve claims that the companies billed Medicare for rehabilitation therapy services that were not reasonable or necessary.
May 26, 2021 12:00 PM - 1:00 PM
Debra Albin-Riley, Sarah G. Benator
Health Care Partner Debra Albin-Riley and Counsel Sarah Benator will present a webinar for the California Society for Healthcare Attorneys (CSHA) on May 26, 2021.
Stephanie Trunk
Similar to the laws of several other states, the North Dakota law contains three main disclosure requirements that apply to “drug manufacturers”
Anne M. Murphy
Several recent surveys and reports by governance and trade associations provide a useful overview of the duties, roles, challenges, and internal relationships of the corporate general counsel, as well as governing board needs and priorities.
D. Jacques Smith, Randall A. Brater, Alexander S. Birkhold, Michael F. Dearington, Mohammed T. Farooqui, Rebecca W. Foreman, Nadia Patel, Laura Zell, Mattie Bowden
Headlines that Matter for Companies and Executives in Regulated Industries
D. Jacques Smith, Randall A. Brater, Alexander S. Birkhold, Michael F. Dearington, Mohammed T. Farooqui, Rebecca W. Foreman, Nadia Patel, Laura Zell
Headlines that Matter for Companies and Executives in Regulated Industries
Stephanie Trunk
Congress recently passed two bills that are designed to educate patients and prescribers about biosimilars and thereby encourage their use and to close a loophole in existing law that allows certain branded drugs to retain longer market exclusivity.
D. Jacques Smith, Alexander S. Birkhold, Michael F. Dearington, Mohammed T. Farooqui, Rebecca W. Foreman, Nadia Patel, Laura Zell
Headlines that Matter for Companies and Executives in Regulated Industries.
Dan H. Renberg, Jeri Freirich*
On Thursday, the Senate Finance Committee held a confirmation hearing for two of the most important health policy officials nominated by President Biden, Chiquita Brooks-LaSure (Administrator, Centers for Medicare and Medicaid Services) and Andrea Palm (Deputy Secretary).
D. Jacques Smith, Randall A. Brater, Alexander S. Birkhold, Michael F. Dearington, Mohammed T. Farooqui, Rebecca W. Foreman, Nadia Patel, Laura Zell
Headlines that Matter for Companies and Executives in Regulated Industries
Hospitals everywhere in the United States should take note: CMS announced on March 26, 2020, that it is lifting its extended 30-day survey suspension for hospitals. Survey activity will now resume.